Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Neurochem Int. 2011 Feb 18;58(8):872–879. doi: 10.1016/j.neuint.2011.02.014

Fig. 1.

Fig. 1

Changes in Src and SSeCKS expression at the mRNA and protein levels after MCAO. (A) (Top) RT-PCR of Src and SSeCKS mRNA at the indicated time points after MCAO; (Bottom) bar graph showing mRNA expression relative to that of β-actin. (B) (Top) Western blot of Src and SSeCKS at the indicated time points after MCAO; (Bottom) bar graph showing protein expression relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Data are representative of at least three independent experiments and presented as means ± S.D.; n = 6 per group; #P < 0.05, *P < 0.01 compared with the sham group. (C) Immunohistochemical staining for Src and SSeCKS at the indicated time points after MCAO. Scale bar = 20 μm.